{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:38:34Z","timestamp":1793320714177,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods & Clinical Development"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omtm.2025.101486","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T02:46:58Z","timestamp":1747277218000},"page":"101486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anti-HIV-1 HSPC-based gene therapy with safety kill switch to defend against and attack HIV-1 infection"],"prefix":"10.1016","volume":"33","author":[{"given":"Qi","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0595-7842","authenticated-orcid":false,"given":"Keval","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Brinkley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natnicha","family":"Jakramonpreeya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjie","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7020-9470","authenticated-orcid":false,"given":"Dong Sung","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101486_bib1","unstructured":"HIV and AIDS https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids."},{"key":"10.1016\/j.omtm.2025.101486_bib2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101486_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav2045","article-title":"No evidence of ongoing HIV replication or compartmentalization in tissues during combination antiretroviral therapy: Implications for HIV eradication","volume":"5","author":"Bozzi","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2025.101486_bib4","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.3390\/v13122512","article-title":"Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection","volume":"13","author":"Lau","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.omtm.2025.101486_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41586-020-2651-8","article-title":"Distinct viral reservoirs in individuals with spontaneous control of HIV-1","volume":"585","author":"Jiang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101486_bib6","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(20)30264-6","article-title":"Kick and kill for HIV latency","volume":"395","author":"Lewin","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2025.101486_bib7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/44755","article-title":"Re-emergence of HIV after stopping therapy","volume":"401","author":"Chun","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101486_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40121-018-0201-6","article-title":"A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population","volume":"7","author":"Chawla","year":"2018","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.omtm.2025.101486_bib9","first-page":"891","article-title":"Cost-effectiveness and budget impact of dolutegravir\/lamivudine for treatment of human immunodeficiency virus (HIV-1) infection in the United States","volume":"27","author":"Butler","year":"2021","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.omtm.2025.101486_bib10","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s10461-019-02721-3","article-title":"Crystal Clear with Active Visualization: Understanding Medication Adherence Among Youth Living with HIV","volume":"24","author":"Christodoulou","year":"2020","journal-title":"AIDS Behav."},{"key":"10.1016\/j.omtm.2025.101486_bib11","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/s41598-020-80247-8","article-title":"Impact of long-term antiretroviral therapy on gut and oral microbiotas in HIV-1-infected patients","volume":"11","author":"Imahashi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101486_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11481-019-09868-9","article-title":"Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury","volume":"16","author":"Yuan","year":"2021","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.omtm.2025.101486_bib13","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/s41591-021-01503-6","article-title":"Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy","volume":"27","author":"Blazkova","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101486_bib14","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5\u039432\/\u039432 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101486_bib15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"H\u00fctter","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101486_bib16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101486_bib17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.cell.2023.02.030","article-title":"HIV-1 remission and possible cure in a woman after haplo-cord blood transplant","volume":"186","author":"Hsu","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2025.101486_bib18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-023-02213-x","article-title":"In-depth virological and immunological characterization of HIV-1 cure after CCR5\u039432\/\u039432 allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Jensen","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101486_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41591-023-02215-9","article-title":"HIV-1 cure after CCR5\u039432\/\u039432 allogeneic hematopoietic stem cell transplantation","volume":"29","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101486_bib20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.humimm.2017.10.001","article-title":"Frequencies of gene variant CCR5-\u039432 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers","volume":"78","author":"Solloch","year":"2017","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.omtm.2025.101486_bib21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1196-1240","article-title":"The role of a mutant CCR5 allele in HIV\u20131 transmission and disease progression","volume":"2","author":"Huang","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101486_bib22","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1182\/blood.V94.1.368.413a47_368_371","article-title":"A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children","volume":"94","author":"Kohn","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101486_bib23","doi-asserted-by":"crossref","first-page":"36ra43","DOI":"10.1126\/scitranslmed.3000931","article-title":"RNA-Based Gene Therapy for HIV with Lentiviral Vector\u2013Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma","volume":"2","author":"DiGiusto","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101486_bib24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.omtm.2020.03.004","article-title":"Experimental Treatment of SIV-Infected Macaques via Autograft of CCR5-Disrupted Hematopoietic Stem and Progenitor Cells","volume":"17","author":"Yu","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101486_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nm.1932","article-title":"Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells","volume":"15","author":"Mitsuyasu","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2025.101486_bib26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/gt.2012.98","article-title":"Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAART","volume":"20","author":"Peterson","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101486_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fcimb.2020.00175","article-title":"TIGIT Blockade: A Multipronged Approach to Target the HIV Reservoir","volume":"10","author":"Holder","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.omtm.2025.101486_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1073\/pnas.232688199","article-title":"Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5","volume":"100","author":"Qin","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.omtm.2025.101486_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1479-0556-7-8","article-title":"Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5","volume":"7","author":"Shimizu","year":"2009","journal-title":"Genet. Vaccine Ther."},{"key":"10.1016\/j.omtm.2025.101486_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.10","article-title":"Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector","volume":"4","author":"Burke","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2025.101486_bib31","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ymthe.2023.12.007","article-title":"In vivo selection of anti-HIV-1 gene-modified human hematopoietic stem\/progenitor cells to enhance engraftment and HIV-1 inhibition","volume":"32","author":"Guo","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101486_bib32","doi-asserted-by":"crossref","first-page":"13110","DOI":"10.1073\/pnas.0705474104","article-title":"Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates","volume":"104","author":"An","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101486_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mtm.2013.11","article-title":"Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor","volume":"1","author":"Wolstein","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101486_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006753","article-title":"Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV\/AIDS","volume":"13","author":"Zhen","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtm.2025.101486_bib35","doi-asserted-by":"crossref","first-page":"11478","DOI":"10.1073\/pnas.94.21.11478","article-title":"Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells","volume":"94","author":"Yang","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101486_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003761","article-title":"Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells","volume":"4","author":"Scholler","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101486_bib37","article-title":"Robust CAR-T memory formation and function via hematopoietic stem cell delivery","volume":"17","author":"Zhen","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omtm.2025.101486_bib38","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/mt.2015.102","article-title":"HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells","volume":"23","author":"Zhen","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101486_bib39","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/bloodadvances.2020004142","article-title":"Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy","volume":"6","author":"Juluri","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.omtm.2025.101486_bib40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1182\/blood-2017-07-793760","article-title":"Infectious complications of CD19-targeted chimeric antigen receptor\u2013modified T-cell immunotherapy","volume":"131","author":"Hill","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101486_bib41","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI85309","article-title":"CD19 CAR\u2013T cells of defined CD4+:CD8+ composition in adult B cell ALL patients","volume":"126","author":"Turtle","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101486_bib42","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2011-02-337360","article-title":"A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells","volume":"118","author":"Wang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101486_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/hum.2018.180","article-title":"A Cetuximab-Mediated Suicide System in Chimeric Antigen Receptor\u2013Modified Hematopoietic Stem Cells for Cancer Therapy","volume":"30","author":"Kao","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2025.101486_bib44","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/s41598-017-02460-2","article-title":"Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2025.101486_bib45","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2009-04-215855","article-title":"A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model","volume":"115","author":"Shimizu","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101486_bib46","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood-2005-11-4388","article-title":"Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus\/liver and CD34+ cell transplantation","volume":"108","author":"Lan","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101486_bib47","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1089\/scd.2016.0193","article-title":"Propagating Humanized BLT Mice for the Study of Human Immunology and Immunotherapy","volume":"25","author":"Smith","year":"2016","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.omtm.2025.101486_bib48","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.omtm.2021.03.007","article-title":"Promoter usage regulating the surface density of CAR molecules may modulate the kinetics of CAR-T cells in vivo","volume":"21","author":"Ho","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101486_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.667393","article-title":"Innate Immune Reconstitution in Humanized Bone Marrow-Liver-Thymus (HuBLT) Mice Governs Adaptive Cellular Immune Function and Responses to HIV-1 Infection","volume":"12","author":"Garcia-Beltran","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101486_bib50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.2011.06310.x","article-title":"Humanized mice as a preclinical tool for infectious disease and biomedical research","volume":"1245","author":"Shultz","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.omtm.2025.101486_bib51","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccr.2008.02.019","article-title":"Matuzumab Binding to EGFR Prevents the Conformational Rearrangement Required for Dimerization","volume":"13","author":"Schmiedel","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omtm.2025.101486_bib52","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/v16020219","article-title":"Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection","volume":"16","author":"Mu","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.omtm.2025.101486_bib53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1128\/JVI.06366-11","article-title":"HIV latency in the humanized BLT mouse","volume":"86","author":"Marsden","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101486_bib55","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.3390\/ijms24076300","article-title":"CAR T Cell Therapy: A Versatile Living Drug","volume":"24","author":"De Marco","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101486_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1253395","article-title":"Strategies for enhancing CAR T cell expansion and persistence in HIV infection","volume":"14","author":"Rothemejer","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101486_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5685","article-title":"Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model","volume":"11","author":"Anthony-Gonda","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101486_bib58","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101486_bib59","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.1105063","article-title":"Clonal Dominance of Hematopoietic Stem Cells Triggered by Retroviral Gene Marking","volume":"308","author":"Kustikova","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.omtm.2025.101486_bib60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101486_bib61","series-title":"Targets in Gene Therapy","article-title":"Suicide Gene Therapy by Herpes Simplex Virus-1 Thymidine Kinase (HSV-TK)","author":"Dey","year":"2011"},{"key":"10.1016\/j.omtm.2025.101486_bib62","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","article-title":"Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy","volume":"365","author":"Di Stasi","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtm.2025.101486_bib63","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.3324\/haematol.2008.001677","article-title":"Retroviral transfer of human CD20 as a suicide gene for adoptive T-cell therapy","volume":"94","author":"Griffioen","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2025.101486_bib64","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.seminhematol.2010.01.009","article-title":"Rituximab-Associated Neutropenia","volume":"47","author":"Dunleavy","year":"2010","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.omtm.2025.101486_bib65","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1600-6143.2006.01288.x","article-title":"Rituximab, an Anti-CD20 Monoclonal Antibody: History and Mechanism of Action","volume":"6","author":"Pescovitz","year":"2006","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.omtm.2025.101486_bib66","first-page":"230","article-title":"Loss of ganciclovir sensitivity by exclusion of thymidine kinase gene from transplanted proinsulin-producing fibroblasts as a gene therapy model for diabetes","volume":"3","author":"Yoshimoto","year":"1996","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2025.101486_bib67","first-page":"731","article-title":"Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene","volume":"4","author":"Yang","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtm.2025.101486_bib68","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ajur.2020.06.004","article-title":"Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer","volume":"8","author":"Yanagisawa","year":"2021","journal-title":"Asian J. Urol."},{"key":"10.1016\/j.omtm.2025.101486_bib69","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1182\/blood-2006-04-015230","article-title":"The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies","volume":"109","author":"Traversari","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101486_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2014.00235","article-title":"The inducible caspase-9 suicide gene system as a \u201csafety switch\u201d to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells","volume":"5","author":"Gargett","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.omtm.2025.101486_bib71","series-title":"Gene Therapy of Solid Cancers Methods in Molecular Biology","first-page":"87","article-title":"iCaspase 9 Suicide Gene System","author":"Zhou","year":"2015"},{"key":"10.1016\/j.omtm.2025.101486_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.755639","article-title":"Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies","volume":"12","author":"Guercio","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101486_bib73","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s40259-019-00354-5","article-title":"Immunogenicity of Chimeric Antigen Receptor T-Cell Therapeutics","volume":"33","author":"Gorovits","year":"2019","journal-title":"BioDrugs"},{"key":"10.1016\/j.omtm.2025.101486_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adj6251","article-title":"Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control","volume":"10","author":"Lu","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.omtm.2025.101486_bib75","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.ymthe.2018.03.001","article-title":"A Rapamycin-Activated Caspase 9-Based Suicide Gene","volume":"26","author":"Stavrou","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2025.101486_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2015.3","article-title":"RNAi-Mediated CCR5 Knockdown Provides HIV-1 Resistance to Memory T Cells in Humanized BLT Mice","volume":"4","author":"Shimizu","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtm.2025.101486_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053492","article-title":"Engineering HIV-1-Resistant T-Cells from Short-Hairpin RNA-Expressing Hematopoietic Stem\/Progenitor Cells in Humanized BLT Mice","volume":"7","author":"Ringpis","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2025.101486_bib78","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1128\/JVI.02717-15","article-title":"Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells","volume":"90","author":"Lee","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.omtm.2025.101486_bib79","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12977-019-0494-x","article-title":"Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency","volume":"16","author":"Telwatte","year":"2019","journal-title":"Retrovirology"},{"key":"10.1016\/j.omtm.2025.101486_bib80","article-title":"Colony Forming Cell (CFC) Assay for Human Hematopoietic Cells","volume":"2195","author":"Sarma","year":"2010","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.omtm.2025.101486_bib81","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/v15020365","article-title":"Human Hematopoietic Stem Cell Engrafted IL-15 Transgenic NSG Mice Support Robust NK Cell Responses and Sustained HIV-1 Infection","volume":"15","author":"Abeynaike","year":"2023","journal-title":"Viruses"}],"container-title":["Molecular Therapy Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125000816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T18:53:38Z","timestamp":1759863218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125000816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":80,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2329050125000816"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101486","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.11.13.623476","asserted-by":"object"}]},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-HIV-1 HSPC-based gene therapy with safety kill switch to defend against and attack HIV-1 infection","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101486"}}